iShares Genomics Immunology and Healthcare ETF (IDNA) Short Interest Ratio & Short Volume

Short interest is the volume of iShares Genomics Immunology and Healthcare ETF shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 7,000 shares of IDNA short. Learn More on iShares Genomics Immunology and Healthcare ETF's current short interest.

iShares Genomics Immunology and Healthcare ETF saw a increase in short interest in May. As of May 15th, there was short interest totaling 7,000 shares, an increase of 29.6% from the previous total of 5,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to iShares Genomics Immunology and Healthcare ETF: Amplify Alternative Harvest ETF (1.20%), Sovereigns Capital Flourish Fund (0.14%), ALPS Clean Energy ETF (1.94%), Direxion Daily NYSE FANG+ Bull 2X Shares (5.27%), First Trust Indxx Innovative Transaction & Process ETF (0.13%), iShares MSCI Agriculture Producers ETF (0.13%), iShares ESG Advanced MSCI EM ETF (0.92%), Schwab Crypto Thematic ETF (0.27%), SPDR S&P Kensho Clean Power ETF (0.06%), SPDR FactSet Innovative Technology ETF (0.42%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

Short selling IDNA is an investing strategy that aims to generate trading profit from iShares Genomics Immunology and Healthcare ETF as its price is falling. IDNA shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for iShares Genomics Immunology and Healthcare ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IDNA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IDNA, twice per month. The most recent reporting period available is May, 15 2025.